Advertisement
Screener

89bio, Inc. Patents: Applications Pending

89bio, Inc. Patent Applications Pending

25 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2025-06-03: Application 19226706; Invention LIQUID FORMULATIONS COMPRISING MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES; Applicant 89Bio, Inc.; Status Docketed New Case - Ready for Examination.
  • 2025-02-10: Application 19102634; Invention METHODS OF TREATMENT OF NASH USING MUTANT FGF-21 PEPTIDE CONJUGATES; Applicant 89Bio, Inc.; Status Docketed New Case - Ready for Examination.
  • 2025-01-21: Application 19032871; Invention COMPOSITIONS AND METHODS OF TREATMENT FOR SEVERE HYPERTRIGLYCERIDEMIA; Applicant 89BIO INC.; Status Docketed New Case - Ready for Examination.
  • 2024-08-23: Application PCTUS2024043581; Invention THERAPEUTIC REGIMENS AND METHODS OF TREATMENT OF NASH USING MUTANT FGF-21 PEPTIDE CONJUGATES; Applicant 89BIO, INC.; Status PCT - International Search Report Mailed to IB.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2025-06-0319226706LIQUID FORMULATIONS COMPRISING MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES89Bio, Inc.Docketed New Case - Ready for ExaminationUS20250381246A1
Boris Schwartsburd
Shaji Joseph
Israel
United States
CENTRAL, DOCKET
2025-02-1019102634METHODS OF TREATMENT OF NASH USING MUTANT FGF-21 PEPTIDE CONJUGATES89Bio, Inc.Docketed New Case - Ready for ExaminationUS20260201005A1
Harry H. Mansbach
Maya Margalit
United States
Israel
CENTRAL, DOCKET
2025-01-2119032871COMPOSITIONS AND METHODS OF TREATMENT FOR SEVERE HYPERTRIGLYCERIDEMIA89BIO INC.Docketed New Case - Ready for ExaminationUS20250325679A1
Harry H. Mansbach
Chih-Ming Tseng
United States
United States
CENTRAL, DOCKET
2024-08-23PCTUS2024043581THERAPEUTIC REGIMENS AND METHODS OF TREATMENT OF NASH USING MUTANT FGF-21 PEPTIDE CONJUGATES89BIO, INC.PCT - International Search Report Mailed to IB
HANK H. MANSBACH
SHAJI JOSEPH
QUOC LE-NGUYEN
CHIH-MING TSENG
United States
United States
United States
United States
MATOS NEGRON, TAINA DEL MAR
2024-06-1218740787CHEMICAL SYNTHESIS OF CYTIDINE-5'-MONOPHOSPHO-N-GLYCYL-SIALIC ACID89bio, Inc.Non Final Action MailedUS20240327447A1
Shaji Joseph
Arthur Bodenmüller
United States
Switzerland
CHO, DAVID H
2024-06-0418733382COMPOSITIONS AND METHODS OF TREATMENT FOR SEVERE HYPERTRIGLYCERIDEMIA89bio, Inc.Docketed New Case - Ready for ExaminationUS20250170249A1
Hank Mansbach
Leo Tseng
United States
United States
CENTRAL, DOCKET
2023-08-24PCTUS2023072811METHODS OF TREATMENT OF NASH USING MUTANT FGF-21 PEPTIDE CONJUGATES89BIO, INC.PCT - International Search Report Mailed to IB
HARRY H. MANSBACH
MAYA MARGALIT
United States
Israel
KIM, HARRY CHONG HYUN
2023-08-2463578565THERAPEUTIC REGIMENS AND METHODS OF TREATMENT OF NASH USING MUTANT FGF-21 PEPTIDE CONJUGATES89bio, Inc.Provisional Application Expired
Hank Mansbach
Shaji Joseph
Quoc Le-Nguyen
United States
United States
United States
2023-04-0463494011METHODS OF TREATMENT OF NASH USING MUTANT FGF-21 PEPTIDE CONJUGATES89BIO, INC.Provisional Application Expired
Hank MANSBACH
United States
2023-02-1763485641COMPOSITION AND METHOD OF TREATMENT FOR SEVERE HYPERTRIGLYCERIDEMIA89BIO, INC.Provisional Application Expired
Hank MANSBACH
Leo TSENG
Teresa PARLI
Shibao FENG
Lulu STERLING
Cynthia L. HARTSFIELD
Germaine D. AGOLLAH
United States
United States
United States
United States
United States
United States
United States
2023-01-3063482078METHODS OF TREATMENT OF NASH USING MUTANT FGF-21 PEPTIDE CONJUGATES89BIO, INC.Provisional Application Expired
Hank MANSBACH
Maya MARGALIT
United States
United States
2022-12-20PCTUS2022082059CHEMICAL SYNTHESIS OF CYTIDINE-5'-MONOPHOSPHO-N-GLYCYL-SIALIC ACID89BIO, INC.PCT - International Search Report Mailed to IB
SHAJI JOSEPH
ARTHUR BODENMULLER
United States
Switzerland
KIM, HARRY CHONG HYUN
2022-12-0663386202COMPOSITION AND METHOD OF TREATMENT FOR SEVERE HYPERTRIGLYCERIDEMIA89BIO, INC.Provisional Application Expired
Hank MANSBACH
Leo TSENG
Teresa PARLI
Shibao FENG
Lulu STERLING
Cynthia L. HARTSFIELD
Germaine D. AGOLLAH
United States
United States
United States
United States
United States
United States
United States
2022-11-0263382058METHODS OF TREATMENT OF NASH USING MUTANT FGF-21 PEPTIDE CONJUGATES89BIO, INC.Provisional Application Expired
Hank MANSBACH
Maya MARGALIT
United States
Israel
2022-08-2663373694METHODS OF TREATMENT OF NASH USING MUTANT FGF-21 PEPTIDE CONJUGATES89BIO, INC.Provisional Application Expired
Hank MANSBACH
United States
2022-08-2663373594COMPOSITION AND METHOD OF TREATMENT FOR SEVERE HYPERTRIGLYCERIDEMIA89BIO, INC.Provisional Application Expired
Hank MANSBACH
Leo TSENG
Teresa PARLI
Shibao FENG
Lulu STERLING
Cynthia L. HARTSFIELD
Germaine D. AGOLLAH
United States
United States
United States
United States
United States
United States
United States
2022-08-2463373352METHODS OF TREATMENT OF NASH USING MUTANT FGF-21 PEPTIDE CONJUGATES89BIO, INC.Provisional Application Expired
Hank MANSBACH
United States
2022-08-1863399165COMPOSITION AND METHOD OF TREATMENT FOR SEVERE HYPERTRIGLYCERIDEMIA89BIO INC.Provisional Application Expired
Hank MANSBACH
Leo TSENG
Rohan PALEKAR
United States
United States
United States
2022-07-2017793953METHODS FOR PROMOTING WEIGHT LOSS89BIO, Inc.Non Final Action MailedUS20230090114A1
Mordechay ROSENSTOCK
Maya MARGALIT
Israel
Israel
KOMATSU, LI N
2022-06-2463355397COMPOSITION AND METHOD OF TREATMENT FOR SEVERE HYPERTRIGLYCERIDEMIA89BIO, INC.Provisional Application Expired
Hank Mansbach
Leo TSENG
Rohan PALEKAR
United States
United States
United States
2022-03-10PCTUS2022019843LIQUID FORMULATIONS COMPRISING MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES89BIO, INC.PCT - International Search Report Mailed to IB
SHAJI JOSEPH
BORIS SCHWARTSBURD
United States
Israel
KIM, HARRY CHONG HYUN
2021-12-2063265744Chemical Synthesis of Cytidine-5'-Monophospho-N-Glycyl-Sialic Acid89bio, Inc.Provisional Application Expired
Shaji Joseph
Arthur Bodenmüller
United States
Switzerland
2021-03-2963167148LIQUID FORMULATIONS COMPRISING MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES89Bio, Inc.Provisional Application Expired
Boris Schwartsburd
Shaji Joseph
Israel
United States
2021-03-1163159717LIQUID FORMULATIONS COMPRISING MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES89bio Inc.Provisional Application Expired
Boris Schwartsburd
Shaji Joseph
Israel
United States
19512478THERAPEUTIC REGIMENS AND METHODS OF TREATMENT OF NASH USING MUTANT FGF-21 PEPTIDE CONJUGATES89BIO INC.Application Undergoing Preexam Processing
Harry H. Mansbach
Shaji Joseph
Quoc Le-Nguyen
Chih-Ming Tseng
United States
United States
United States
United States